Colorectal and gastric cancer: Current and future therapeutic approaches. Part 2 - Immunotherapy

December 06, 2023 00:18:13
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 2 - Immunotherapy
COR2ED - Oncology Medical Conversation
Colorectal and gastric cancer: Current and future therapeutic approaches. Part 2 - Immunotherapy

Dec 06 2023 | 00:18:13

/

Show Notes

In this podcast series, Dr. Jenny Seligmann (University of Leeds, UK), Dr. Autumn McRee (University of North Carolina, USA) and Dr. Dominik Modest (Charité University of Medicine, Germany) discuss the different therapeutic options available in colorectal and gastric cancer.

This second episode focuses on recent developments in immunotherapy approaches in metastatic colorectal and gastric cancer – specifically whether immunotherapy should be used alone, in combination with other treatments or with chemotherapy. Data from several clinical trials are discussed such as KEYNOTE-177, CheckMate 142, CheckMate 649, KEYNOTE 062, and NICHE. The experts also consider the appropriate treatment regimens for MSI-high and MSS colorectal and gastric cancer patients and whether CPS is an appropriate biomarker for gastric cancer.

Other Episodes

Episode

April 15, 2025 00:21:27
Episode Cover

The HER2 Diagnostic and Treatment Landscape in NSCLC

Episode 1: Identifying HER2-directed NSCLC: The Medical Oncologist and Pathologist perspectives  This is the first episode of a two-part series on the HER2 diagnostic...

Listen

Episode

December 06, 2023 00:25:10
Episode Cover

Cáncer de próstata: Inhibidores de PARP - lo que las enfermeras necesitan saber

COR2ED Educación Médica: Pablo Peinado, coordinador de Enfermería de Investigación, y la Dra. Elena Castro, oncóloga médica, quienes trabajan en el Hospital Universitario Virgen...

Listen

Episode

December 06, 2023 00:22:48
Episode Cover

Prostate cancer: Which mCSPC patients benefit from early treatment intensification? Case-based discussion

Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC) in this GU...

Listen